Provider
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Program effective Date: Aug 14, 2017
Search Results
Displaying 2651 - 2660 of 4204 results
Provider
P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing
Program effective Date: Apr 28, 2017
Provider
P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs
Program effective Date: Aug 01, 2018
Provider
P35-17 Addition of Drug to the Substance Reduction Therapy Prior Authorization with Quantity Limit Program
Program effective Date: Jun 13, 2017
Provider
P49-17 Two New Medicare Advantage Prescription Drug Products in 2018
Program effective Date: Sep 25, 2017
Provider
P11-17 Pre-Admission Notification Requirement for Admissions Effective June 1, 2017
Program effective Date: Apr 04, 2017
Provider
P76-17 Centurion moving to Blue Cross for Claims Administration Services
Program effective Date: Dec 07, 2017
Provider
P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA
Program effective Date: Jan 09, 2018
Provider
2018 May Bulletins
Program effective Date: May 01, 2018
Provider
P25-17 Addition of New Drugs to the Hepatitis C Second Generation Antivirals Prior Authorization (PA) with Quantity Limit (QL) Program
Program effective Date: May 25, 2017